1. A multi‐model approach to predict efficacious clinical dose for an anti‐TGF‐β antibody (GC2008) in the treatment of osteogenesis imperfecta. (27th September 2022) Authors: Mavroudis, Panteleimon D.; Pillai, Nikhil; Wang, Qingping; Pouzin, Clemence; Greene, Benjamin; Fretland, Jennifer Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 11(2022) Page Start: 1485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Covariate analysis of tusamitamab ravtansine, a DM4 anti‐CEACAM5 antibody‐drug conjugate, based on first‐in‐human study. (22nd February 2022) Authors: Pouzin, Clemence; Tod, Michel; Chadjaa, Mustapha; Fagniez, Nathalie; Nguyen, Laurent Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 3(2022) Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗